State of Dental AI Funding: Where Investors Are Placing Their Bets

State of Dental AI Funding: Where Investors Are Placing Their Bets

The dental artificial intelligence sector has attracted well over half a billion dollars in venture capital funding across its leading companies, with investors making increasingly concentrated bets on the platforms they believe will dominate the market. From Series C mega-rounds to strategic acquisitions by dental industry incumbents, the capital flowing into dental AI reflects a growing conviction that artificial intelligence will become as fundamental to dental practice as the digital radiograph itself.

Here is where the money is going — and what it signals about the future of AI-powered dentistry.

The Big Three: Overjet, Pearl, and VideaHealth

Overjet has emerged as one of the best-funded dental AI companies, having raised approximately $106 million in total funding. The company’s $53.2 million Series C round, led by General Catalyst with participation from Insight Partners and the March of Dimes, valued the company at a significant premium and underscored investor confidence in its dual payer-provider business model. Overjet’s ability to serve both dental insurance carriers and clinical practices gives it a diversified revenue base that few competitors can match. Founded by researchers from MIT, the company holds multiple FDA clearances and has built integrations with major practice management and imaging platforms.

Pearl has raised over $58 million in venture funding, including a $32 million Series B round. Pearl’s approach centers on its Second Opinion product, an FDA-cleared AI platform that provides real-time pathology detection on dental radiographs. The company has pursued an aggressive go-to-market strategy targeting both DSOs and independent practices, and has differentiated itself through a focus on practice-level analytics and patient communication tools. Pearl’s investor base includes Craft Ventures and Left Lane Capital, reflecting interest from growth-stage investors who see a clear path to scalable recurring revenue.

VideaHealth has raised over $45 million in funding to build its AI-powered dental diagnostic platform. Backed by investors including Spark Capital and Zetta Venture Partners, VideaHealth has focused on developing highly accurate caries detection models and has published peer-reviewed research validating its algorithms against board-certified dentists. The company has targeted large group practices and DSOs as its primary market, and has been building out treatment planning capabilities beyond initial diagnostic detection.

Beyond Diagnostics: The Expanding Investment Landscape

While diagnostic imaging AI has captured the most venture dollars, investors are also funding AI companies across the broader dental workflow. TrueLark, the AI-powered patient communication platform formerly known as FrontdeskAI, raised $20 million in its Series B round to expand its automated scheduling, recall, and patient engagement tools for dental practices and DSOs. The company’s AI handles patient phone calls, texts, and web chats to reduce no-shows and fill open appointments — a critical revenue optimization tool for multi-location dental groups.

Dental Intelligence, which provides AI-driven practice analytics and performance optimization for dental groups, has similarly attracted venture interest. The company’s platform aggregates data from practice management systems to surface actionable insights on scheduling efficiency, treatment acceptance, and revenue opportunities — functions that become exponentially more valuable at DSO scale.

In the clinical workflow space, companies building AI-powered treatment planning, clinical documentation, and voice-driven charting tools have also emerged. Viva AI, another emerging player in dental front office automation, has attracted attention for its comprehensive AI operating system approach that combines conversational AI with outbound patient engagement and practice analytics — positioning itself as one of the more ambitious entrants in the DSO-focused AI space.

The integration of large language models into dental practice software for automated clinical note generation and treatment narrative creation represents a new frontier that investors are watching closely.

M&A Activity and Strategic Investments

The mergers and acquisitions landscape in dental AI has been heating up as established dental technology companies look to add AI capabilities through acquisition rather than internal development. Henry Schein, one of the world’s largest dental distributors, made a strategic investment in VideaHealth, signaling the distribution giant’s intent to integrate AI into its technology ecosystem. Patterson Dental and other major distributors have also been evaluating AI partnerships and investments as part of their digital transformation strategies.

“We are seeing dental AI follow the same maturation pattern as healthcare AI more broadly — an initial wave of venture funding for pure-play startups, followed by strategic investment and acquisition from industry incumbents who need the technology but lack the internal R&D to build it.”

— Healthcare technology investment analyst

Planet DDS, the cloud-based practice management company backed by private equity firm KKR, has also been building AI features into its Denticon platform, suggesting that the next wave of dental AI innovation may come not from standalone AI companies but from AI capabilities embedded directly into the practice management systems that dental offices use every day.

Key Funding Metrics at a Glance

• Overjet: ~$106M total raised | Series C | Investors include General Catalyst, Insight Partners
• Pearl: ~$58M total raised | Series B | Investors include Craft Ventures, Left Lane Capital
• VideaHealth: ~$45M+ total raised | Series B | Investors include Spark Capital, Zetta Venture Partners
• TrueLark: $20M+ raised | Series B | AI patient communication and scheduling
• Dental Intelligence: Venture-backed | AI practice analytics and performance optimization

What Investors Are Watching Next

Several themes are likely to shape the next wave of dental AI investment:

• Platform consolidation: Investors expect the market to consolidate around two to three dominant diagnostic AI platforms, with smaller players either being acquired or pivoting to niche applications.
• Revenue-cycle AI: Tools that use AI to optimize insurance verification, claims submission, and denial management represent a large addressable market that is still underpenetrated.
• Generative AI for clinical workflows: Large language model applications for clinical documentation, patient communication, and treatment planning are attracting early-stage funding.
• International expansion: As US market leaders secure dominant domestic positions, international expansion — particularly into European and Asian markets with different regulatory frameworks — presents the next growth vector.
• AI-powered orthodontic planning: The intersection of AI with clear aligner therapy and orthodontic treatment planning has drawn investment interest, with companies developing AI tools for case assessment and treatment simulation.

The dental AI funding landscape reflects a sector that has moved beyond early-stage experimentation into a mature investment category. With FDA clearances in hand, enterprise DSO contracts signed, and revenue scaling, the leading dental AI companies are now competing not just for venture capital but for market dominance. For DSO executives and dental industry stakeholders, understanding who is funding these companies — and why — provides critical insight into where the technology is headed and which platforms are most likely to endure.

DSO News tracks funding rounds, M&A activity, and investment trends across the dental AI ecosystem. Subscribe to our newsletter for weekly updates.